GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 May 2015 10:52 AM
RNS
Director/PDMR Shareholding - Replacement
26 May 2015 10:29 AM
RNS
Director/PDMR Shareholding
22 May 2015 03:44 PM
RNS
Director/PDMR Shareholding
22 May 2015 02:46 PM
RNS
Blocklisting Interim Review
15 May 2015 05:16 PM
RNS
Director/PDMR Shareholding
15 May 2015 05:14 PM
RNS
Director/PDMR Shareholding
15 May 2015 05:09 PM
RNS
Director/PDMR Shareholding
13 May 2015 12:16 PM
RNS
Director/PDMR Shareholding
12 May 2015 01:10 PM
RNS
Director/PDMR Shareholding
12 May 2015 01:07 PM
RNS
Director/PDMR Shareholding
11 May 2015 11:44 AM
RNS
Director/PDMR Shareholding
11 May 2015 11:38 AM
RNS
Director/PDMR Shareholding
08 May 2015 07:00 AM
RNS
Result of AGM
07 May 2015 12:30 PM
RNS
Board and Committee changes
06 May 2015 02:20 PM
RNS
Director/PDMR Shareholding
06 May 2015 12:00 PM
RNS
1st Quarter Results
01 May 2015 07:00 AM
RNS
Total Voting Rights
01 May 2015 07:00 AM
RNS
FDA approves BREO ELLIPTA for adults with asthma
30 Apr 2015 04:53 PM
RNS
Director/PDMR Shareholding
29 Apr 2015 03:25 PM
RNS
Director/PDMR Shareholding
28 Apr 2015 10:52 AM
RNS
GSK candidate vaccine for prevention of shingles
28 Apr 2015 10:42 AM
RNS
Director/PDMR Shareholding
23 Apr 2015 04:40 PM
RNS
Director/PDMR Shareholding
20 Apr 2015 02:59 PM
RNS
Director/PDMR Shareholding
20 Apr 2015 02:06 PM
RNS
Director/PDMR Shareholding
20 Apr 2015 02:01 PM
RNS
Director/PDMR Shareholding
20 Apr 2015 01:59 PM
RNS
Director/PDMR Shareholding
14 Apr 2015 03:36 PM
RNS
Director/PDMR Shareholding
14 Apr 2015 09:35 AM
RNS
Director/PDMR Shareholding
13 Apr 2015 06:30 PM
RNS
Director/PDMR Shareholding
13 Apr 2015 03:32 PM
RNS
Director/PDMR Shareholding
13 Apr 2015 02:41 PM
RNS
Director/PDMR Shareholding
13 Apr 2015 02:39 PM
RNS
Director/PDMR Shareholding
10 Apr 2015 02:37 PM
RNS
Director/PDMR Shareholding
08 Apr 2015 01:21 PM
RNS
Director/PDMR Shareholding
01 Apr 2015 04:10 PM
RNS
Director/PDMR Shareholding
01 Apr 2015 10:33 AM
RNS
Total Voting Rights
30 Mar 2015 04:46 PM
RNS
Director/PDMR Shareholding
25 Mar 2015 12:00 PM
RNS
Notice of AGM
20 Mar 2015 07:00 AM
RNS
US FDA Advisory Committee on BREO ELLIPTA
19 Mar 2015 02:26 PM
RNS
Director Declaration
16 Mar 2015 03:23 PM
RNS
Director/PDMR Shareholding
13 Mar 2015 07:00 AM
RNS
GSK completes partial sale of Aspen
12 Mar 2015 03:14 PM
RNS
GSK intends to sell part holding in Aspen
11 Mar 2015 04:35 PM
RNS
Director/PDMR Shareholding
11 Mar 2015 04:27 PM
RNS
Director/PDMR Shareholding
09 Mar 2015 05:33 PM
RNS
Director/PDMR Shareholding
06 Mar 2015 05:48 PM
RNS
Director/PDMR Shareholding
02 Mar 2015 02:38 PM
RNS
Director/PDMR Shareholding
02 Mar 2015 01:30 PM
RNS
Annual Report 2014 on Form 20-F

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings